Actively Recruiting
Prevention of Intra-uterine Adhesions Following Laparoscopic and Laparotomic Myomectomy
Led by University Hospital, Ghent · Updated on 2025-01-27
30
Participants Needed
1
Research Sites
253 weeks
Total Duration
On this page
Sponsors
U
University Hospital, Ghent
Lead Sponsor
N
Nordic Pharma SAS
Collaborating Sponsor
AI-Summary
What this Trial Is About
Clinical study on the prevention of intrauterine adhesions after laparoscopic or laparotomic myomectomy. Myomas are common in women of reproductive age and myomectomy can lead to intra-uterine adhesions, which can be detrimental to fertility. This study investigates whether the use of an intrauterine gel can prevent the development of these adhesions.
CONDITIONS
Official Title
Prevention of Intra-uterine Adhesions Following Laparoscopic and Laparotomic Myomectomy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female aged between 18 and 45 years
- Diagnosis of intramural and/or subserosal myoma (FIGO 3-6) or hybrid myoma (FIGO 2-5) scheduled for laparoscopic or laparotomic myomectomy
- No intra-uterine adhesions confirmed by preoperative diagnostic hysteroscopy
You will not qualify if you...
- Pregnancy
- Laparoscopic or laparotomic myomectomy combined with operative hysteroscopy
- Presence of endometritis
- Use of other antiadhesion methods
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Ghent
Ghent, Belgium
Actively Recruiting
Research Team
S
Steffi Van Wessel, Dr.
CONTACT
S
Steven Weyers, Prof. dr.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here